Target intelligence / Profile preview

Polyhistidine tag (6×His tag) (6×His)

Target
6×His
Molecular classification
Peptide tag, Affinity tag, Epitope tag
01

Overview

The 6×His tag is a synthetic peptide consisting of six consecutive histidine residues, commonly engineered into the N- or C-terminus of recombinant proteins to facilitate their purification and detection. It functions by binding with high affinity to immobilized divalent metal ions, such as nickel (Ni2+) or cobalt (Co2+), through coordinate covalent bonding in a process known as Immobilized Metal Affinity Chromatography (IMAC) (Hochuli et al., 1988). This tag is one of the most prevalent tools in biotechnology due to its small size, which typically minimizes impact on protein solubility, and its ability to remain stable under both native and denaturing conditions (Terpe, 2003). In a therapeutic context, the 6×His tag is not a target for drug intervention but rather a manufacturing aid; it is often removed from the final drug product using site-specific proteases to ensure the protein maintains its native conformation and to minimize potential adverse immune responses in patients (Khan et al., 2012). Consequently, while it is indispensable for protein characterization and production, it does not possess an endogenous biological role or direct involvement in disease pathogenesis.

Other names
His6 tagHexahistidine tagHis-tag6-His tagPoly-His tagHHHHHH epitope
02

Mechanism of action

The 6×His tag facilitates the purification of recombinant proteins through Immobilized Metal Affinity Chromatography (IMAC). The imidazole rings of the histidine residues form coordinate covalent bonds with transition metal ions (such as Ni2+ or Co2+) immobilized on a resin (Porath et al., 1975; Hochuli et al., 1988). Elution is typically achieved using imidazole, which competes for the metal binding sites, or by lowering the pH to protonate the histidine residues (Bornhorst & Falke, 2000).

03

Biological functions

Protein purificationProtein detectionProtein immobilizationWestern blottingImmunoprecipitation
04

Disease associations

None
05

Safety considerations

Potential immunogenicity in clinical applicationsInterference with protein tertiary structure or foldingAlteration of protein biological activityRequirement for proteolytic removal in therapeutic protein manufacturing
06

Interacting drugs

Nickel-nitrilotriacetic acid (Ni-NTA)

2 more in the full profile.

Beyond the preview

Go deeper on Polyhistidine tag (6×His tag) (6×His).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyhistidine tag (6×His tag) (6×His).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call